Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 03/08/2011
Mellbin LG et al. – Patients with type 2 diabetes and myocardial infarction have a poor prognosis. Glucose–lowering drugs appear to be of prognostic importance. Insulin may be associated with an increased risk of non–fatal cardiac events, while metformin seems to be protective against risk of death.
